{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:07:48Z","timestamp":1776416868377,"version":"3.51.2"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2020,5,18]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Nonalcoholic Fatty Liver Disease (NAFLD) includes a variety of changes including nonalcoholic\nfatty liver, cirrhosis and Hepatocellular Carcinoma (HCC), which are associated with metabolic\ndisorders and cardiovascular diseases. The pathogenesis of NAFLD is complex and multifactorial.\nMany studies have shown that estrogen has a protective effect on premenopausal women with metabolic\ndisorders and non-alcoholic fatty liver disease. Estrogen supplements may, at least in theory,\nprevent the development and progression of NAFLD. Phytoestrogen is extracted from plants, especially\nlegumes, whose molecular structure and biological activity are similar to those of mammals estrogen,\ntherefore it could replace the role of estrogen and prevent the occurrence of adverse reactions to\nestrogen. In this article, we review the published literature related to phytoestrogens and NAFLD as\nwell as suggest the possible mechanisms that may underlie the association between phytoestrogens and\nNAFLD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557520666200103114123","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T18:17:40Z","timestamp":1578075460000},"page":"578-583","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phytoestrogens and NAFLD: Possible Mechanisms of Action"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4681-5961","authenticated-orcid":true,"given":"Hui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Dentistry, China-Japan Union Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-5993","authenticated-orcid":true,"given":"Erna","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Gastroenterolgy and Hepatology, China-Japan Union Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterolgy and Hepatology, China-Japan Union Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterolgy and Hepatology, China-Japan Union Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterolgy and Hepatology, China-Japan Union Hospital, Jilin University, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","DOI":"10.1201\/9781420027594","author":"Yildiz F.","year":"2005","unstructured":"Yildiz F.;  Phytoestrogens in Functional Foods CRC Press 2005","journal-title":"Phytoestrogens in Functional Foods CRC Press"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3945\/an.112.002154","volume":"3","author":"Slavin J.L.","year":"2012","unstructured":"Slavin J.L.; Lloyd B.; Health benefits of fruits and vegetables. Adv Nutr 2012,3(4),506-516","journal-title":"Adv Nutr"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","volume":"57","author":"Hashimoto Y.","year":"2017","unstructured":"Hashimoto Y.; Hamaguchi M.; Fukuda T.; Ohbora A.; Kojima T.; Fukui M.; Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 2017,57(1),89-97","journal-title":"Endocrine"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","volume":"34","author":"Ballestri S.","year":"2017","unstructured":"Ballestri S.; Nascimbeni F.; Baldelli E.; Marrazzo A.; Romagnoli D.; Lonardo A.; NAFLD as Sexual Dimorphic Disease: Role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther 2017,34(6),1291-1326","journal-title":"Adv Ther"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","volume":"9","author":"Gutierrez-Grobe Y.","year":"2010","unstructured":"Gutierrez-Grobe Y.; Ponciano-Rodr\u00edguez G.; Ramos M.H.; Uribe M.; M\u00e9ndez-S\u00e1nchez N.; Prevalence of non-alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 2010,9(4),402-409","journal-title":"Ann Hepatol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","author":"Bruno S.","year":"2005","unstructured":"Bruno S.; Maisonneuve P.; Castellana P.; Rotmensz N.; Rossi S.; Maggioni M.; Persico M.; Colombo A.; Monasterolo F.; Casadei-Giunchi D.; Desiderio F.; Stroffolini T.; Sacchini V.; Decensi A.; Veronesi U.; Incidence and risk factors for nonalcoholic\n  steatohepatitis: Prospective study of 5408 women enrolled in\n  Italian tamoxifen chemoprevention trial. BMJ 2005(7497),932","journal-title":"BMJ"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"McKenzie J.","year":"2006","unstructured":"McKenzie J.; Fisher B.M.; Jaap A.J.; Stanley A.; Paterson K.; Sattar N.; Effects of HRT on liver enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial. Clin Endocrinol (Oxf) 2006,65(1),40-44","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","volume":"18","author":"Hamaguchi M.","year":"2012","unstructured":"Hamaguchi M.; Kojima T.; Ohbora A.; Takeda N.; Fukui M.; Kato T.; Aging is arisk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol 2012,18,237-243","journal-title":"World J Gastroenterol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","volume":"59","author":"Yang J.D.","year":"2014","unstructured":"Yang J.D.; Abdelmalek M.F.; Pang H.; Guy C.D.; Smith A.D.; Diehl A.M.; Suzuki A.; Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 2014,59,1406-1414","journal-title":"Hepatology"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.27097","volume":"60","author":"Yoneda M.","year":"2014","unstructured":"Yoneda M.; Thomas E.; Sumida Y.; Schiffet E.R.; The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology 2014,60,1792","journal-title":"Hepatology"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1007\/s10620-015-3660-6","volume":"60","author":"Luo F.","year":"2015","unstructured":"Luo F.; Ishigami M.; Achiwa K.; Ishizu Y.; Kuzuya T.; Honda T.; Hayashi K.; Ishikawa T.; Katano Y.; Gotoet H.; Raloxifene ameliorates liver fibrosis of nonalcoholic steatohepatitis induced by choline-deficient high-fat diet in ovariectomized mice. Dig Dis Sci 2015,60,2730-2273","journal-title":"Dig Dis Sci"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","volume":"65","author":"McKenzie J.","year":"2006","unstructured":"McKenzie J.; Fisher B.M.; Jaap A.J.; Stanley A.; Paterson K.; Sattar N.; Effects of HRT on liver enzyme levels in women with type 2 diabetes: A randomized placebo-controlled trial. Clin Endocrinol (Oxf) 2006,65,40-44","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","volume":"122","author":"Clark J.M.","year":"2002","unstructured":"Clark J.M.; Brancati F.L.; Diehl A.M.; Nonalcoholic fatty liver disease. Gastroenterology 2002,122,1649-1657","journal-title":"Gastroenterology"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","volume":"64","author":"Klair J.S.","year":"2016","unstructured":"Klair J.S.; Yang J.D.; Abdelmalek M.F.; Guy C.; D.; Gill, R.M.; Yates, K.; Unalp-Arida, A.; Lavine, J.E.; Clark, J.M.; Diehl, A.M.; Suzuki, A. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology 2016,64,85-91","journal-title":"Hepatology"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","volume":"15","author":"Yang J.D.","year":"2017","unstructured":"Yang J.D.; Abdelmalek M.F.; Guy C.D.; Gill R.M.; Lavine J.E.; Yates K.; Klair J.; Terrault N.A.; Clark J.M.; Unalp-Arida A.; Diehl A.M.; Suzuki A.; Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2017,15,127-131","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2217\/17455057.4.1.41","volume":"4","author":"Villa E.","year":"2008","unstructured":"Villa E.; Role of estrogen in liver cancer. Womens Health (Lond) 2008,4,41-50","journal-title":"Womens Health (Lond)"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/cncr.28912","volume":"120","author":"Yang D.","year":"2014","unstructured":"Yang D.; Hanna D.L.; Usher J.; LoCoco J.; Chaudhari P.; Lenz H-J.; Setiawan V.W.; El-Khoueiry A.; Impact of sex on the survival of patients with hepatocellular carcinoma: A surveillance, epidemiology, and end results analysis. Cancer 2014,120,3707-3716","journal-title":"Cancer"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fct.2013.07.048","volume":"60","author":"Jung J.H.","year":"2013","unstructured":"Jung J.H.; Kim H.S.; The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. Food Chem Toxicol 2013,60,404-412","journal-title":"Food Chem Toxicol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mnfr.201300112","volume":"58","author":"Jeon S.","year":"2014","unstructured":"Jeon S.; Park Y.J.; Kwon Y.H.; Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-\/-) mice fed a high-fat diet. Mol Nutr Food Res 2014,58(4),830-841","journal-title":"Mol Nutr Food Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.EJ15-0056","volume":"62","author":"Kim J.H.","year":"2015","unstructured":"Kim J.H.; Kim Y.J.; Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice. Endocr J 2015,62(6),531-542","journal-title":"Endocr J"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0007114510005799","volume":"106","author":"Huang C.","year":"2011","unstructured":"Huang C.; Qiao X.; Dong B.; Neonatal exposure to genistein ameliorates high-fat diet-induced non-alcoholic steatohepatitis in rats. Br J Nutr 2011,106(1),105-113","journal-title":"Br J Nutr"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ijo.2010.256","volume":"35","author":"Kim M.H.","year":"2011","unstructured":"Kim M.H.; Park J.S.; Jung J.W.; Byun K.W.; Kang K.S.; Lee Y.S.; Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int J Obes (Lond) 2011,35(8),1019-1030","journal-title":"Int J Obes (Lond)"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jnutbio.2016.08.007","volume":"38","author":"Panneerselvam S.","year":"2016","unstructured":"Panneerselvam S.; Packirisamy R.M.; Bobby Z.; Elizabeth Jacob S.; Sridhar M.G.; Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). J Nutr Biochem 2016,38,57-69","journal-title":"J Nutr Biochem"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/mnfr.201500689","volume":"60","author":"Park H.S.","year":"2016","unstructured":"Park H.S.; Hur H.J.; Kim S.H.; Park S.J.; Hong M.J.; Sung M.J.; Kwon D.Y.; Kim M.S.; Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol Nutr Food Res 2016,60(9),1944-1955","journal-title":"Mol Nutr Food Res"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1258\/ebm.2011.010265","volume":"236","author":"Hess D.","year":"2011","unstructured":"Hess D.; Igal R.A.; Genistein downregulates de novo lipid synthesis and impairs cell proliferation in human lung cancer cells. Exp Biol Med (Maywood) 2011,236(6),707-713","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ijo.2010.256","volume":"35","author":"Kim M.H.","year":"2011","unstructured":"Kim M.H.; Park J.S.; Jung J.W.; Byun K.W.; Kang K.S.; Lee Y.S.; Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism. Int J Obes (Lond) 2011,35(8),1019-1030","journal-title":"Int J Obes (Lond)"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/ars.2010.3834","volume":"15","author":"Kay H.Y.","year":"2011","unstructured":"Kay H.Y.; Kim W.D.; Hwang S.J.; Choi H.S.; Gilroy R.K.; Wan Y.J.; Kim S.G.; Nrf2 inhibits LXR\u03b1-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid Redox Signal 2011,15(8),2135-2146","journal-title":"Antioxid Redox Signal"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2009.12.006","volume":"48","author":"Kim Y.W.","year":"2010","unstructured":"Kim Y.W.; Kim Y.M.; Yang Y.M.; Kim T.H.; Hwang S.J.; Lee J.R.; Kim S.C.; Kim S.G.; Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic Biol Med 2010,48(4),567-578","journal-title":"Free Radic Biol Med"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jnutbio.2016.08.007","volume":"38","author":"Panneerselvam S.","year":"2016","unstructured":"Panneerselvam S.; Packirisamy R.M.; Bobby Z.; Elizabeth Jacob S.; Sridhar M.G.; Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity). J Nutr Biochem 2016,38,57-69","journal-title":"J Nutr Biochem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1753-0407.2009.00045.x","volume":"1","author":"Mohamed Salih S.","year":"2009","unstructured":"Mohamed Salih S.; Nallasamy P.; Muniyandi P.; Periyasami V.; Carani Venkatraman. A Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance. J Diabetes 2009,1(4),278-287","journal-title":"J Diabetes"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mnfr.201300112","volume":"58","author":"Jeon S.","year":"2014","unstructured":"Jeon S.; Park Y.J.; Kwon Y.H.; Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-\/-) mice fed a high-fat diet. Mol Nutr Food Res 2014,58(4),830-841","journal-title":"Mol Nutr Food Res"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1017\/S0007114510002266","volume":"104","author":"Kim M.H.","year":"2010","unstructured":"Kim M.H.; Kang K.S.; Lee Y.S.; The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br J Nutr 2010,104(9),1333-1342","journal-title":"Br J Nutr"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbalip.2014.11.006","volume":"1851","author":"Gao X.","year":"2015","unstructured":"Gao X.; van der Veen J.N.; Hermansson M.; Ordo\u00f1ez M.; Gomez-Mu\u00f1oz A.; Vance D.E.; Jacobs R.L.; Decreased lipogenesis in white adipose tissue contributes to the resistance to high fat diet-induced obesity in phosphatidylethanolamine N-methyltransferase-deficient mice. Biochim Biophys Acta 2015,1851(2),152-162","journal-title":"Biochim Biophys Acta"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/oby.20907","volume":"23","author":"Miller C.N.","year":"2015","unstructured":"Miller C.N.; Yang J.Y.; Avra T.; Ambati S.; Della-Fera M.A.; Rayalam S.; Baile C.A.; A dietary phytochemical blend prevents liver damage associated with adipose tissuemobilization in ovariectomized rats. Obesity (Silver Spring) 2015,23(1),112-119","journal-title":"Obesity (Silver Spring)"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/mnfr.201500689","volume":"60","author":"Park H.S.","year":"2016","unstructured":"Park H.S.; Hur H.J.; Kim S.H.; Park S.J.; Hong M.J.; Sung M.J.; Kwon D.Y.; Kim M.S.; Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice. Mol Nutr Food Res 2016,60(9),1944-1955","journal-title":"Mol Nutr Food Res"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mnfr.201300112","volume":"58","author":"Jeon S.","year":"2014","unstructured":"Jeon S.; Park Y.J.; Kwon Y.H.; Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-\/-) mice fed a high-fat diet. Mol Nutr Food Res 2014,58(4),830-841","journal-title":"Mol Nutr Food Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.intimp.2011.01.036","volume":"11","author":"Ji G.","year":"2011","unstructured":"Ji G.; Yang Q.; Hao J.; Guo L.; Chen X.; Hu J.; Leng L.; Jiang Z.; Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol 2011,11(6),762-768","journal-title":"Int Immunopharmacol"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1089\/jmf.2008.1069","volume":"12","author":"Park Y.J.","year":"2009","unstructured":"Park Y.J.; Jang Y.M.; Kwon Y.H.; Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y cells. J Med Food 2009,12(3),528-535","journal-title":"J Med Food"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2014-307142","volume":"64","author":"Anh\u00ea F.F.","year":"2015","unstructured":"Anh\u00ea F.F.; Roy D.; Pilon G.; Dudonn\u00e9 S.; Matamoros S.; Varin T.V.; Garofalo C.; Moine Q.; Desjardins Y.; Levy E.; Marette A.; A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015,64(6),872-883","journal-title":"Gut"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00394-008-0723-x","volume":"47","author":"Ohtomo T.","year":"2008","unstructured":"Ohtomo T.; Uehara M.; Pe\u00f1alvo J.L.; Adlercreutz H.; Katsumata S.; Suzuki K.; Takeda K.; Masuyama R.; Ishimi Y.; Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures. Eur J Nutr 2008,47(5),273-279","journal-title":"Eur J Nutr"},{"key":"ref=41","volume":"9","author":"Nakatsu C.H.","year":"2014","unstructured":"Nakatsu C.H.; Armstrong A.; Clavijo A.P.; Martin B.R.; Barnes S.; Weaver C.M.; Fecal bacterial community changes associated with isoflavone metabolites in postmenopausal women after soy bar consumption. PLoS One 2014,9(10)","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"M572","DOI":"10.1111\/j.1750-3841.2012.02901.x","volume":"77","author":"Hong S.W.","year":"2012","unstructured":"Hong S.W.; Choi J.Y.; Chung K.S.; Culture-based and denaturing gradient gel electrophoresis analysis of the bacterial community from Chungkookjang, a traditional Korean fermented soybean food. J Food Sci 2012,77(10),M572-M578","journal-title":"J Food Sci"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ejcn.2014.23","volume":"68","author":"Frankenfeld C.L.","year":"2014","unstructured":"Frankenfeld C.L.; Atkinson C.; W\u00e4h\u00e4l\u00e4 K.; Lampe J.W.; Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur J Clin Nutr 2014,68(4),526-530","journal-title":"Eur J Clin Nutr"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/mnfr.201500445","volume":"60","author":"Madak-Erdogan Z.","year":"2016","unstructured":"Madak-Erdogan Z.; Gong P.; Zhao Y.C.; Xu L.; Wrobel K.U.; Hartman J.A.; Wang M.; Cam A.; Iwaniec U.T.; Turner R.T.; Twaddle N.C.; Doerge D.R.; Khan I.A.; Katzenellenbogen J.A.; Katzenellenbogen B.S.; Helferich W.G.; Dietary licorice root supplementation reduces diet-induced weight gain, lipid deposition, and hepatic steatosis in ovariectomized mice without stimulating reproductive tissues and mammary gland. Mol Nutr Food Res 2016,60(2),369-380","journal-title":"Mol Nutr Food Res"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.tem.2016.08.001","volume":"27","author":"Chen K.L.","year":"2016","unstructured":"Chen K.L.; Madak-Erdogan Z.; Estrogen and Microbiota Crosstalk: Should We Pay Attention? Trends Endocrinol Metab 2016,27(11),752-755","journal-title":"Trends Endocrinol Metab"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T09:12:41Z","timestamp":1593681161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178055\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,5,18]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557520666200103114123","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}